Article: COLORADO STATE'S ANIMAL CANCER CENTER INVESTIGATES PROMISING DRUG COMBINATION TO TREAT BONE CANCER

Colorado State University issued the following press release:

The Colorado State University Animal Cancer Center is studying a promising combination of a new and an old cancer drug that may increase chemotherapy effectiveness without increasing unwanted side effects. The study may eventually be useful for the treatment of both human and animal cancer.

The center, which is seeking pet owners with dogs diagnosed with bone cancer to participate in the study, is combining a common chemotherapy drug, called doxorubicin or Adriamycin, with valproic acid, also called Depakote, a drug that previously has been used to treat seizures in dogs and humans. An enzyme called histone deacetylase, which ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!